Dietary flavonoids and allied phenolic compounds are thought to be beneficial in the control of diabetes and its complications, because of their ability to inhibit oxidative stress, protein glycation and to act as neuroprotectants. Following ingestion by humans, polyphenolic compounds entering the large intestine undergo extensive metabolism by interaction with colonic microbiota and it is metabolites and catabolites of the parent compounds that enter the circulatory system. The aim of this study was to investigate the inhibitory activity of some colonic microbiota-derived polyphenol catabolites against advanced glycation endproducts (AGEs) formation in vitro and to determine their ability, at physiological concentrations, to counteract mild oxidative stress of cultured human neuron cells. This study demonstrated that ellagitannin-derived catabolites (urolithins and pyrogallol) are the most effective antiglycative agents, whereas chlorogenic acid-derived catabolites (dihydrocaffeic acid, dihydroferulic acid and feruloylglycine) were most effective in combination in protecting neuronal cells in a conservative in vitro experimental model. In conclusion, some polyphenolic catabolites, generated in vivo in the colon, were able in vitro to counteract two key features of diabetic complications, i.e. protein glycation and neurodegeneration. These observations could lead to a better control of these events, which are usually correlated with hyperglycemia.

Antiglycative and neuroprotective activity of colon-derived polyphenol catabolites / Verzelloni, Elena; C., Pellacani; Tagliazucchi, Davide; S., Tagliaferri; L., Calani; L. G., Costa; F., Brighenti; G., Borges; A., Crozier; Conte, Angela; D., Del Rio. - In: MOLECULAR NUTRITION & FOOD RESEARCH. - ISSN 1613-4125. - STAMPA. - 55:1(2011), pp. 35-43. [10.1002/mnfr.201000525]

Antiglycative and neuroprotective activity of colon-derived polyphenol catabolites

VERZELLONI, Elena;TAGLIAZUCCHI, Davide;CONTE, Angela;
2011-01-01

Abstract

Dietary flavonoids and allied phenolic compounds are thought to be beneficial in the control of diabetes and its complications, because of their ability to inhibit oxidative stress, protein glycation and to act as neuroprotectants. Following ingestion by humans, polyphenolic compounds entering the large intestine undergo extensive metabolism by interaction with colonic microbiota and it is metabolites and catabolites of the parent compounds that enter the circulatory system. The aim of this study was to investigate the inhibitory activity of some colonic microbiota-derived polyphenol catabolites against advanced glycation endproducts (AGEs) formation in vitro and to determine their ability, at physiological concentrations, to counteract mild oxidative stress of cultured human neuron cells. This study demonstrated that ellagitannin-derived catabolites (urolithins and pyrogallol) are the most effective antiglycative agents, whereas chlorogenic acid-derived catabolites (dihydrocaffeic acid, dihydroferulic acid and feruloylglycine) were most effective in combination in protecting neuronal cells in a conservative in vitro experimental model. In conclusion, some polyphenolic catabolites, generated in vivo in the colon, were able in vitro to counteract two key features of diabetic complications, i.e. protein glycation and neurodegeneration. These observations could lead to a better control of these events, which are usually correlated with hyperglycemia.
55
1
35
43
Antiglycative and neuroprotective activity of colon-derived polyphenol catabolites / Verzelloni, Elena; C., Pellacani; Tagliazucchi, Davide; S., Tagliaferri; L., Calani; L. G., Costa; F., Brighenti; G., Borges; A., Crozier; Conte, Angela; D., Del Rio. - In: MOLECULAR NUTRITION & FOOD RESEARCH. - ISSN 1613-4125. - STAMPA. - 55:1(2011), pp. 35-43. [10.1002/mnfr.201000525]
Verzelloni, Elena; C., Pellacani; Tagliazucchi, Davide; S., Tagliaferri; L., Calani; L. G., Costa; F., Brighenti; G., Borges; A., Crozier; Conte, Angela; D., Del Rio
File in questo prodotto:
File Dimensione Formato  
Antiglycative and neuroprotective activity of.pdf

non disponibili

Tipologia: Versione pubblicata dall'editore
Dimensione 217.07 kB
Formato Adobe PDF
217.07 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/647842
Citazioni
  • ???jsp.display-item.citation.pmc??? 38
  • Scopus 159
  • ???jsp.display-item.citation.isi??? 141
social impact